test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AUTLAutolus Therapeutics Plc
Recent Activity
1.76%
$55.438M
15.272M shares@ $3.63 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Increased 28.48%
1.7%
$53.568M
1.221M shares@ $43.89 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
1.52%
$47.76M
4M shares@ $11.94 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Decreased -8.58%
1.48%
$46.508M
5.577M shares@ $8.35 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 0.87%
1.41%
$44.283M
4.096M shares@ $10.81 avg price
ABVXAbivax Sa
Recent Activity
Decreased -14.36%
1.31%
$41.232M
3.579M shares@ $11.53 avg price
TGTXTg Therapeutics Inc
Recent Activity
Decreased -39.89%
1.28%
$40.348M
1.725M shares@ $23.39 avg price
MNMDMind Medicine Mindmed Inc
Recent Activity
Increased 15.75%
1.28%
$40.2M
7.065M shares@ $5.69 avg price
KURAKura Oncology Inc
Recent Activity
Increased 410.33%
1.22%
$38.367M
1.964M shares@ $19.55 avg price
GERNGeron Corp
Recent Activity
Decreased -41.73%
1.1%
$34.391M
7.575M shares@ $4.54 avg price